Analyst Consensus ?
ConsensusBuy24 ratings
Bullish2083.3%
Neutral416.7%
Bearish00.0%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
Sempra (SRE) analyst consensus, price targets, and firm-level rating history from FN2 Research.
1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| BMO Capital | Outperform | Outperform | Maintain | Jul 22, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 9, 2026 |
| Truist Securities | Buy | Buy | Maintain | May 18, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 21, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Mar 23, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Mar 18, 2026 |
| UBS | Neutral | Neutral | Maintain | Mar 6, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Mar 5, 2026 |
| Argus Research | Buy | Hold | Upgrade | Mar 4, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Nov 24, 2025 |
| Goldman Sachs | Buy | Neutral | Upgrade | Nov 14, 2025 |
| Jefferies | Hold | Hold | Maintain | Oct 22, 2025 |
| Mizuho | Outperform | Outperform | Maintain | Sep 24, 2025 |
| Guggenheim | Buy | Buy | Maintain | Feb 26, 2025 |
| Ladenburg Thalmann | Buy | Buy | Maintain | May 29, 2024 |
| RBC Capital | Outperform | Outperform | Maintain | Mar 6, 2024 |
| B of A Securities | Buy | Buy | Maintain | Mar 28, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Apr 26, 2022 |
| Keybanc | Overweight | Downgrade | Mar 7, 2022 | |
| Seaport Global | Neutral | Buy | Downgrade | Apr 7, 2021 |
| CFRA | Strong Buy | Buy | Upgrade | Mar 18, 2020 |
| Bank of America | Buy | Neutral | Upgrade | Oct 11, 2018 |
| Argus | Buy | Hold | Upgrade | May 21, 2018 |
| ISI Group | Buy | Neutral | Upgrade | Jun 9, 2014 |
| Bank oferica | Buy | Buy | Maintain | May 4, 2012 |
Upside is calculated against the persisted current price $88.82. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | David Arcaro | $108 | $92.88 | +21.6% | Jul 22, 2026 |
| BMO Capital | Analyst unavailable | $102 | $92.79 | +14.8% | Jul 22, 2026 |
| Jefferies | Analyst unavailable | $101 | $92.78 | +13.7% | Jul 16, 2026 |
| Barclays | Analyst unavailable | $103 | $95.15 | +16.0% | Jul 9, 2026 |
| Morgan Stanley | Analyst unavailable | $105 | $91.9 | +18.2% | Jun 24, 2026 |
| Truist Financial | Analyst unavailable | $104 | $90.43 | +17.1% | May 18, 2026 |
| Morgan Stanley | Analyst unavailable | $104 | $93.27 | +17.1% | Apr 21, 2026 |
| Wells Fargo | Analyst unavailable | $118 | $93.38 | +32.9% | Apr 21, 2026 |
| Truist Financial | Richard Sunderland | $108 | $93.38 | +21.6% | Apr 20, 2026 |
| Barclays | Analyst unavailable | $105 | $96.16 | +18.2% | Apr 15, 2026 |
| Morgan Stanley | Analyst unavailable | $101 | $93.34 | +13.7% | Feb 20, 2026 |
| Barclays | Nicholas Campanella | $95 | $86.22 | +7.0% | Feb 3, 2026 |
| Morgan Stanley | David Arcaro | $97 | $86.8 | +9.2% | Feb 2, 2026 |
| UBS | Analyst unavailable | $100 | $85.98 | +12.6% | Jan 22, 2026 |
| UBS | Analyst unavailable | $92 | $85.98 | +3.6% | Jan 22, 2026 |
| Barclays | Nicholas Campanella | $97 | $85.98 | +9.2% | Jan 22, 2026 |
| Morgan Stanley | Analyst unavailable | $95 | $84.89 | +7.0% | Jan 21, 2026 |
| Wells Fargo | Shahriar Pourreza | $112 | $92.55 | +26.1% | Jan 20, 2026 |
| UBS | Analyst unavailable | $96 | $87.91 | +8.1% | Dec 17, 2025 |
| Morgan Stanley | Analyst unavailable | $91 | $88.57 | +2.5% | Dec 16, 2025 |
| Morgan Stanley | Analyst unavailable | $98 | $91.12 | +10.3% | Nov 20, 2025 |
| Wells Fargo | Analyst unavailable | $115 | $93.17 | +29.5% | Oct 27, 2025 |
| Morgan Stanley | David Arcaro | $99 | $91.88 | +11.5% | Oct 22, 2025 |
| BMO Capital | James Thalacker | $99 | $92.29 | +11.5% | Oct 22, 2025 |
| Jefferies | Analyst unavailable | $89 | $92.29 | +0.2% | Oct 22, 2025 |
| BTIG | Analyst unavailable | $106 | $92.29 | +19.3% | Oct 21, 2025 |
| Barclays | Analyst unavailable | $101 | $91.29 | +13.7% | Oct 20, 2025 |
| Evercore ISI | Analyst unavailable | $105 | $92.46 | +18.2% | Oct 6, 2025 |
| Barclays | Analyst unavailable | $80 | $81.72 | -9.9% | Aug 26, 2025 |
| Barclays | Nicholas Campanella | $71 | $74.9 | -20.1% | Jul 10, 2025 |
| Morgan Stanley | David Arcaro | $87 | $76.75 | -2.0% | May 22, 2025 |
| Morgan Stanley | David Arcaro | $89 | $73.31 | +0.2% | Apr 23, 2025 |
| Jefferies | Julien Dumoulin-Smith | $75 | $69.73 | -15.6% | Apr 14, 2025 |
| Morgan Stanley | Analyst unavailable | $86 | $70 | -3.2% | Mar 20, 2025 |
| Jefferies | Julian Dumoulin-Smith | $98 | $85.96 | +10.3% | Oct 24, 2024 |
| BMO Capital | James Thalacker | $96 | $84.83 | +8.1% | Oct 21, 2024 |
| Mizuho Securities | Anthony Crowdell | $93 | $84.83 | +4.7% | Oct 21, 2024 |
| Barclays | Nicholas Campanella | $89 | $83.63 | +0.2% | Oct 1, 2024 |
| Morgan Stanley | David Arcaro | $85 | $83.02 | -4.3% | Sep 25, 2024 |
| BMO Capital | James Thalacker | $93 | $81.37 | +4.7% | Sep 12, 2024 |
| Morgan Stanley | David Arcaro | $80 | $81.67 | -9.9% | Aug 23, 2024 |
| Mizuho Securities | Anthony Crowdell | $88 | $79.96 | -0.9% | Aug 16, 2024 |
| Barclays | Nicholas Campanella | $87 | $78.99 | -2.0% | Aug 13, 2024 |
| BMO Capital | James Thalacker | $90 | $77.57 | +1.3% | Aug 9, 2024 |
| Mizuho Securities | Anthony Crowdell | $86 | $77.67 | -3.2% | May 17, 2024 |
| Mizuho Securities | Anthony Crowdell | $79 | $70.97 | -11.1% | Apr 4, 2024 |
| Barclays | Eric Beaumont | $77 | $71.96 | -13.3% | Feb 22, 2024 |
| Raymond James | James Thalacker | $84 | $74.8 | -5.4% | Jan 11, 2024 |
| BMO Capital | James Thalacker | $84 | $74.84 | -5.4% | Jan 11, 2024 |
| J.P. Morgan | Christopher Turnure | $86 | $76.01 | -3.2% | Jan 4, 2024 |
| Barclays | Eric Beaumont | $76 | $70.12 | -14.4% | Nov 1, 2023 |
| Barclays | Eric Beaumont | $156 | $70.3 | +75.6% | Oct 19, 2023 |
| Citigroup | Analyst unavailable | $42.75 | $41.21 | -51.9% | Apr 28, 2022 |
| Credit Suisse | Analyst unavailable | $45 | $41.34 | -49.3% | Apr 26, 2022 |
| Morgan Stanley | Analyst unavailable | $42 | $43.12 | -52.7% | Apr 20, 2022 |
| RBC Capital | Shelby Tucker | $39.5 | $32.68 | -55.5% | Jan 24, 2022 |
| Vertical Research | Jonathan Arnold | $39.5 | $34.18 | -55.5% | Jan 10, 2022 |
| Wells Fargo | Sarah Akers | $36.25 | $30.9 | -59.2% | Nov 8, 2021 |
Track every rating change on SRE the moment it posts. Free to start.
Start free